186 related articles for article (PubMed ID: 21223815)
1. [Clinical features of urological malignancies with paraneoplastic syndromes].
Yang Y; Mao QZ; Li HZ; Rong S; Yan WG; Ji ZG; Liu GH; Xu WF; Xiao H; Wang HJ
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3411-4. PubMed ID: 21223815
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic syndromes and oncological outcomes in renal cancer.
Ikuerowo SO; Ojewuyi OO; Omisanjo OA; Abolarinwa AA; Bioku MJ; Doherty AF
Niger J Clin Pract; 2019 Sep; 22(9):1271-1275. PubMed ID: 31489865
[TBL] [Abstract][Full Text] [Related]
3. Is there an association between advanced stage of renal cell carcinoma and paraneoplastic syndrome?
Ding GX; Song NH; Feng CC; Xia GW; Jiang HW; Hua LX; Ding Q
Med Princ Pract; 2012; 21(4):370-4. PubMed ID: 22237047
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic symptoms: cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma.
Ding GX; Feng CC; Song NH; Fang ZJ; Xia GW; Jiang HW; Hua LX; Ding Q
Urol Oncol; 2013 Nov; 31(8):1820-5. PubMed ID: 22534085
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic syndromes in urology].
Pérez Arbej JA; Nogueras Gimeno MA; Martínez Pérez E; Abad Menor F; Arnáiz Esteban F; Fernández Rosaénz J; Guinda Sevillano C; Espuela Orgaz R
Arch Esp Urol; 1991 Oct; 44(8):943-9. PubMed ID: 1796856
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia-leukocytosis syndrome associated with lung cancer.
Hiraki A; Ueoka H; Takata I; Gemba K; Bessho A; Segawa Y; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
Lung Cancer; 2004 Mar; 43(3):301-7. PubMed ID: 15165088
[TBL] [Abstract][Full Text] [Related]
7. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
Barocas DA; Rabbani F; Scherr DS; Vaughan ED
BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic manifestations of renal cell carcinoma.
Gold PJ; Fefer A; Thompson JA
Semin Urol Oncol; 1996 Nov; 14(4):216-22. PubMed ID: 8946620
[TBL] [Abstract][Full Text] [Related]
9. Stauffer's syndrome with jaundice, a paraneoplastic manifestation of renal cell carcinoma: a case report.
Tomadoni A; García C; Márquez M; Ayala JC; Prado F
Arch Esp Urol; 2010 Mar; 63(2):154-6. PubMed ID: 20378939
[TBL] [Abstract][Full Text] [Related]
10. Stauffer's syndrome variant associated with renal cell carcinoma.
Giannakos G; Papanicolaou X; Trafalis D; Michaelidis I; Margaritis G; Christofilakis C
Int J Urol; 2005 Aug; 12(8):757-9. PubMed ID: 16174051
[TBL] [Abstract][Full Text] [Related]
11. Higher than expected association of clinical prostate and bladder cancers.
Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
J Urol; 2005 May; 173(5):1526-9. PubMed ID: 15821472
[TBL] [Abstract][Full Text] [Related]
12. Coincidence of bladder and prostate cancer.
Chun TY
J Urol; 1997 Jan; 157(1):65-7. PubMed ID: 8976217
[TBL] [Abstract][Full Text] [Related]
13. Genitourinary cancers in older adults.
Morganstern D; Garnick MB
Clin Geriatr Med; 1998 May; 14(2):333-65. PubMed ID: 9536109
[TBL] [Abstract][Full Text] [Related]
14. [Detection of urological and male genital tumors diagnosed in Beijing Hospital 1995 - 2004].
Liu M; Wang JY; Zhang YG; Zhu SC; Lu ZH; Wan B
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2423-5. PubMed ID: 18036323
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survival.
Walther MM; Johnson B; Culley D; Shah R; Weber J; Venzon D; Yang JC; Linehan WM; Rosenberg SA
J Urol; 1998 Mar; 159(3):718-22. PubMed ID: 9474133
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.
Kim HL; Belldegrun AS; Freitas DG; Bui MH; Han KR; Dorey FJ; Figlin RA
J Urol; 2003 Nov; 170(5):1742-6. PubMed ID: 14532767
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic syndromes in primary liver cell carcinoma in Nigeria.
Teniola SO; Ogunleye IO
Trop Geogr Med; 1994; 46(1):20-2. PubMed ID: 8165731
[TBL] [Abstract][Full Text] [Related]
18. Stauffer syndrome in transitional cell carcinoma of the bladder.
Moreno-Palacios J; Wingartz-Plata H; Pardo-Belasteguigoitia P; Moreno-Aranda J
Arch Esp Urol; 2011 Nov; 64(9):911-3. PubMed ID: 22155881
[TBL] [Abstract][Full Text] [Related]
19. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
Singh AK; Mashtare TL; McCloskey SA; Seixas-Mikelus SA; Kim HL; May KS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1086-94. PubMed ID: 20350797
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestation.
Mauri D; Pentheroudakis G; Tolis C; Chojnacka M; Pavlidis N
Urol Oncol; 2005; 23(5):318-22. PubMed ID: 16144664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
